biochemical recurrence - malecare.org

Changes of PSA Doubling Time is Associated with Disease Progression in Men with Biochemically Relapsed Prostate Cancer Treated with Intermittent Androgen Deprivation

Researchers at the The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland studied the relationship between the change of PSA doubling time (PSADT) and disease progression during intermittent androgen deprivation (IAD) therapy for prostate cancer. They retrospectively analyzed the data from 96 men diagnosed with biochemically relapsed prostate cancer (BRPC) who [...]

By Malecare|2017-10-19T10:53:12-04:00April 17th, 2011|Advanced Prostate Cancer, Drugs & Treatments, Hormone Therapy, Uncategorized, Understanding APC|0 Comments

Phase II Study of Nitric Oxide for Men with Increasing PSAs After Primary Treatment for Prostate Cancer

Biochemical recurrence of prostate cancer after primary therapy (PSA only) remains a significant problem. Deciding on the best treatment options for men who have failed primary therapy without documented evidence of metastatic disease remains limited and controversial. Androgen deprivation therapy (ADT), the usual next step for biochemical recurrence does prolong the time to further disease [...]

By Malecare|2017-10-19T10:53:45-04:00July 26th, 2010|Advanced Prostate Cancer, Clinical Trials, Clinical Trials, Drugs & Treatments, Research, Technology, Uncategorized, Understanding APC|7 Comments

Time Between Treatment And PSA Recurrence Predicts Death From Prostate Cancer

According to a study last year at Fox Chase Cancer Center, men whose prostate specific antigen (PSA) rise within 18 months of having primary radiotherapy are more likely to develop advanced prostate cancer and die of their disease. […]

By Malecare|2010-05-27T09:15:04-04:00May 27th, 2010|Advanced Prostate Cancer, Drugs & Treatments, End-Of-Life, General Information, Hormone Therapy, Radiotherapy, Uncategorized, Understanding APC|0 Comments